Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Magenta Therapeutics Inc (NQ: MGTA )

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 11, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Magenta Therapeutics Inc

< Previous 1 2 3 4 Next >
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Eargo (NASDAQ:EAR) stock increased by 50.0% to $6.84 during Thursday's regular session. The current volume of 90.4 million shares is 5474.6% of Eargo's... 
Via Benzinga
33 Stocks Moving In Thursday's Mid-Day Session
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe... 
Via Benzinga
Mid-Morning Market Update: Markets Open Lower; Walgreens Tops Q1 Views
Following the market opening Thursday, the Dow traded down 0.52% to 36,217.32 while the NASDAQ fell 1.09% to 14,935.90. The S&P also fell, dropping 0.52% to 4,676.00. The U.S... 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... 
Via Benzinga
Magenta Therapeutics Highlights Recent Pipeline Progress and Milestone Expectations for 2022
From Magenta Therapeutics
Via Business Wire
58 Biggest Movers From Yesterday
Gainers Eargo, Inc. (NASDAQ: EAR) shares climbed 59.7% to close at $7.28 on Thurs after the company announced the Department of Justice confirmed to it that the previously-... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
Upgrades For Canada Goose Holdings Inc (NYSE: 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Freeline Therapeutics (NASDAQ:FRLN) stock increased by 58.1% to $3.1 during Thursday's pre-market session. The company's market cap stands at $111.0... 
Via Benzinga
Magenta Therapeutics to Present at the J.P. Morgan Healthcare Conference and the B. Riley Virtual Oncology Conference
From Magenta Therapeutics
Via Business Wire
Magenta Therapeutics Highlights Presentations of Data Related to Stem Cell Mobilization and Targeted Conditioning at the 2021 American Society of Hematology (ASH) Annual Meeting
From Magenta Therapeutics
Via Business Wire
Magenta Therapeutics Reports Third Quarter Financial Results and Program Highlights
From Magenta Therapeutics, Inc.
Via Business Wire
Magenta Therapeutics Announces Data Presentations Related to its Mobilization and Conditioning Programs at the 2021 American Society of Hematology (ASH) Annual Meeting
From Magenta Therapeutics
Via Business Wire
Magenta Therapeutics Appoints Jeffrey Humphrey, M.D. as Chief Medical Officer
From Magenta Therapeutics, Inc.
Via Business Wire
Magenta Therapeutics to Participate in 2021 Cantor Virtual Global Healthcare Conference
From Magenta Therapeutics, Inc.
Via Business Wire
Magenta Therapeutics' Shares Gain As FDA Signs Off Blood Cancer Candidate To Enter Human Trial
The FDA has signed off Magenta Therapeutics Inc's (NASDAQ: MGTA) IND application for MGTA-117. Related Content: Magenta Therapeutics Stock Drops As FDA... 
Via Benzinga
Exposures Product Safety
Magenta Therapeutics Announces IND Clearance for MGTA-117 Targeted Conditioning Clinical Trial
From Magenta Therapeutics, Inc.
Via Business Wire
Magenta Therapeutics Reports Second Quarter Financial Results and Recent Program Highlights
From Magenta Therapeutics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 3, 2021
Upgrades For SolarEdge Technologies Inc (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 5) Alkermes plc (NASDAQ: ALKS)... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
During Thursday's morning session, 77 companies made new 52-week lows. Areas of Interest: The largest company in terms of market cap to set a new 52-week low... 
Via Benzinga
Magenta Therapeutics to Participate in Upcoming Healthcare Investor Conferences in August
From Magenta Therapeutics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Chembio Diagnostics (NASDAQ: CEMI) shares rose 102.91% to $4.18 during Wednesday's pre-market session. The market value of their outstanding shares is at $84.6 million.... 
Via Benzinga
Magenta Therapeutics Stock Drops As FDA Issues Clinical Hold On Blood Cancer Candidate IND
The FDA has instituted a clinical hold on Magenta Therapeutics Inc's (NASDAQ: MGTA) Investigational New Drug Application (IND) of MGTA-117. In June, the... 
Via Benzinga
Exposures Product Safety
Magenta Therapeutics Announces Update on U.S. FDA Investigational New Drug Application for MGTA-117 in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome
From Magenta Therapeutics, Inc.
Via Business Wire
Magenta Therapeutics Appoints Caren Deardorf as Chief Commercial Officer
From Magenta Therapeutics, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 29, 2021
Upgrades For Nutrien Ltd (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2021
Upgrades According to Raymond James, the prior rating for Welltower Inc (NYSE:WELL) was changed from Market Perform to Strong Buy. For the first quarter, Welltower had an... 
Via Benzinga
Magenta Therapeutics Appoints Thomas Beetham as Chief Legal Officer
From Magenta Therapeutics
Via Business Wire
Magenta Therapeutics Announces Additional Preliminary Positive Results from Ongoing Phase 2 Clinical Trial of MGTA-145 and Plerixafor in Patients with Multiple Myeloma at the American Society of Clinical Oncology (ASCO) Annual Meeting
From Magenta Therapeutics
Via Business Wire
Magenta Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
From Magenta Therapeutics
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.